The effects of the PDE4 inhibitor roflumilast on cognitive performance after a cerebrovascular accident: a double-blind randomized placebo-controlled trial with an open label extension (ROSTMEMA).

J PsychopharmacolApr 24, 2026 (epub)
Clinical ResearchNeurologyPsychiatryOpen access

Jill Kerckhoffs, Ieke Winkens, Arthur Ooghe et al.

✦ AI-curated · Sources linked

In 30 seconds

This double-blind randomized placebo-controlled trial evaluated the effects of the PDE4 inhibitor roflumilast on cognitive performance in 100 post-stroke patients aged 41-70 with memory complaints. The study found that roflumilast significantly improved memory scores on the VLT and Rivermead Behavioural Memory Test, with effect sizes reaching 0.33-0.40 after adjusting for baseline covariates.

Key findings

  • Roflumilast improved VLT delayed recall scores with effect sizes of 0.33-0.40 after adjusting for baseline covariates.
  • Participants receiving roflumilast showed non-significant moderate effect sizes of 0.31-0.36 on memory tests at endpoint.
  • In the open label extension, all memory test scores improved with medium to large significant effect sizes (Partial η 2: 0.079-0.171).
  • Adverse events were similar between the roflumilast and placebo groups.

Why it matters

Post-Stroke Cognitive Impairment (PSCI) is a significant challenge in recovery, and effective treatments are limited. This study suggests that roflumilast may offer a new pharmacological option to enhance cognitive function in affected patients.

Source

Published in J Psychopharmacol. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Neurology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.